Table 3.
Multilevel models of the odds of an encounter being via telehealth by cancer type post COVID-19.
|
|
Cancer type | ||||||||||||||
|
|
|
|
Breast | P value | Colorectal | P value | Lung | P value | |||||||
| Patient characteristics, ORa (95% CI) | |||||||||||||||
|
|
Age at diagnosis (years) | 1.01 (0.99-1.02) | .24 | 1.00 (0.99-1.02) | .59 | 1.01 (0.99-1.03) | .25 | ||||||||
|
|
Male sex | N/Ab |
|
0.53 (0.35-0.81)c | .003 | 1.12 (0.80-1.57) | .51 | ||||||||
| Oncologist characteristics, OR (95% CI) | |||||||||||||||
|
|
Cancer specialty | ||||||||||||||
|
|
|
Medical oncology | Refd |
|
Ref |
|
Ref |
|
|||||||
|
|
|
Radiation oncology | 0.81 (0.30-2.21) | .69 | 0.73 (0.25-2.15) | .57 | 5.42 (1.44-20.45)c | .01 | |||||||
|
|
|
Surgery | 0.38 (0.20-0.71)c | .003 | 0.49 (0.21-1.15) | .10 | 0.68 (0.18-2.58) | .57 | |||||||
|
|
Patient volume | ||||||||||||||
|
|
|
Low | Ref |
|
Ref |
|
Ref |
|
|||||||
|
|
|
Medium | 3.84 (1.09-13.62)c | .04 | 1.24 (0.38-4.07) | .74 | 1.98 (0.32-12.14) | .46 | |||||||
|
|
|
High | 1.09 (0.40-2.96) | .87 | 0.92 (0.37-2.28) | .84 | 0.34 (0.09-1.28) | .11 | |||||||
|
|
Multisite physician | 0.58 (0.28-1.22) | .15 | 0.70 (0.30-1.63) | .40 | 0.26 (0.09-0.76)c | .01 | ||||||||
|
|
Hub-hospital physician | 2.21 (1.17-4.15)c | .01 | 1.10 (0.51-2.38) | .82 | 1.46 (0.45-4.72) | .53 | ||||||||
| Intraclass correlation coefficient | |||||||||||||||
|
|
Oncologist | 0.163 | N/A | 0.144 | N/A | 0.333 | N/A | ||||||||
|
|
Patient | 0.171 | N/A | 0.135 | N/A | 0.142 | N/A | ||||||||
|
|
Overall | 0.334 | N/A | 0.286 | N/A | 0.475 | N/A | ||||||||
aOR: odds ratio.
bN/A: not applicable.
cSignificant, P<.05.
dRef: reference.